Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of MAP Pharmaceuticals, Inc. (MAPP)
30 Enero 2013 - 10:04AM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of MAP Pharmaceuticals, Inc. (“MAP” or the “Company”)
(NasdaqGS: MAPP) for potential breaches of fiduciary duties in
connection with their conduct related to the sale of the Company to
Allergan Inc. (NYSE: AGN) in an all-cash deal valued at
approximately $958 million. Under the terms of the proposed
transaction, MAP’s stockholders will receive $25 in cash for each
share of MAP’s common stock they own. The proposed transaction is
structured as a tender offer and may be effectuated without a
shareholder vote.
Request more information now by clicking here:
www.faruqilaw.com/MAP. There is no cost or
obligation to you.
The investigation focuses on whether MAP’s Board of Directors
breached their fiduciary duties to the Company’s stockholders by
failing to conduct an adequate and fair sales process prior to
agreeing to this proposed transaction, whether and by how much this
proposed transaction undervalues the Company to the detriment of
MAP’s shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in MAP and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/MAP or contact Juan E. Monteverde,
Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone
at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Map Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
Más de Faruqi & Faruqi, LLP Artículos de Noticias